Published in AIDS Weekly, May 5th, 1997
The data was reported in the May 1997 edition of the Journal of Virology. The more than year-long study showed that CD4+ monocyte cells, which are normally sensitive to HIV, are protected from HIV infection when treated with this new form of gene therapy, known as genetic antisense.
The study was conducted by Enzo Biochem, New York, New York, and researchers including Jeffrey Laurence, M.D., New York Hospital-Cornell University Medical College. They reported...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.